Chest CT Using Low-concentration Iodine Contrast Media
Pulmonary Disease
About this trial
This is an interventional other trial for Pulmonary Disease
Eligibility Criteria
Inclusion Criteria: Patients aged 19 years or older, weighing less than 90 kg, and BMI less than 30 who underwent contrast-enhanced chest CT alone Exclusion Criteria: Under the age of 18 Cases where contrast-enhanced CT cannot be performed Heart failure Pregnancy If patients cannot voluntarily give written consent to participate in this clinical trial In the case of an anatomical deformation that may interfere with image analysis in the previous image Patients with a history of hypersensitivity to IOBRIX, components of IOBRIX, and iodine-based drugs Patients with severe thyroid disease (Iodine may accumulate in the thyroid gland and worsen symptoms.) Those who are judged unsuitable by the tester for other reasons Patients aged 19 years or older, weighing less than 90 kg, and BMI less than 30 who underwent contrast-enhanced chest CT alone
Sites / Locations
- Seoul St. Mary's Hospital, The Catholic University of Korea
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Active Comparator
Experimental
Experimental
Experimental
Chest CT evaluation (Administrate contrast media for CECT)
Chest CT evaluation (Experimental 1)
Chest CT evaluation (Experimental 2)
Chest CT evaluation (Experimental 3)
Patients who are planned chest contrast enhanced CT scan ; Conventional concentration iodine contrast agents with the conventional tube voltage
Patients who are planned chest contrast enhanced CT scan ; Conventional concentration iodine contrast agents with the low tube voltage
Patients who are planned chest contrast enhanced CT scan ; Low concentration iodine contrast agents with the low tube voltage)
Patients who are planned chest contrast enhanced CT scan; Ultra Low concentration iodine contrast agents with the low tube voltage)